A History of Prescription Drug Monitoring Programs in the United States: Political Appeal and Public Health Efficacy

被引:28
|
作者
Holmgren, A. Jay [1 ]
Botelho, Alyssa [2 ,3 ]
Brandt, Allan M. [3 ,4 ]
机构
[1] Harvard Univ, Harvard Business Sch, Boston, MA 02115 USA
[2] Harvard Med Sch, Med Scientist Training Program, Boston, MA 02115 USA
[3] Harvard Univ, Dept Hist Sci, Cambridge, MA 02138 USA
[4] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA 02115 USA
关键词
IMPLEMENTATION; ADDICTION; DIVERSION; OPIOIDS; LEGAL; NEED;
D O I
10.2105/AJPH.2020.305696
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Prescription drug monitoring programs (PDMPs) have become a widely embraced policy to address the US opioid crisis. Despite mixed scientific evidence on their effectiveness at improving health and reducing overdose deaths, 49 states and Washington, DC have adopted PDMPs, and they have received strong bipartisan legislative support. This article explores the history of PDMPs, tracking their evolution from paper-based administrative databases in the early 1900s to modern-day electronic systems that intervene at the point of care. We focus on two questions: how did PDMPs become so widely adopted in the United States, and how did they gain popularity as an intervention in the contemporary opioid crisis? Through this historical approach, we evaluate what PDMPs reflect about national drug policy and broader cultural understandings of substance use disorder in the United States today.
引用
收藏
页码:1191 / 1197
页数:7
相关论文
共 50 条
  • [1] Prescription drug monitoring programs in the United States of America
    Felix, Sausan El Burai
    Mack, Karin
    REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH, 2014, 36 (04): : 270 - 276
  • [2] Prescription Drug Monitoring Programs and Prescription Opioid-Related Outcomes in the United States
    Puac-Polanco, Victor
    Chihuri, Stanford
    Fink, David S.
    Cerda, Magdalena
    Keyes, Katherine M.
    Li, Guohua
    EPIDEMIOLOGIC REVIEWS, 2020, 42 (01) : 134 - 153
  • [3] Prescription drug monitoring programs
    Miller, Michael M.
    Brown, Randall T.
    AMERICAN FAMILY PHYSICIAN, 2007, 75 (06) : 810 - 811
  • [4] Optimizing the Use of State Prescription Drug Monitoring Programs for Public Safety
    Green, Sherry L.
    Pfenning, Stacey
    JOURNAL OF NURSING REGULATION, 2015, 6 (03) : 4 - 10
  • [5] Prescription Drug Monitoring Programs Combating prescription drug misuse
    Gudoski, Anthony J.
    NURSE PRACTITIONER, 2015, 40 (11): : 28 - 33
  • [6] Prescription Drug Monitoring Programs and Drug Overdoses
    不详
    PHARMACEUTICAL MEDICINE, 2018, 32 (04) : 304 - 304
  • [8] The evolution of prescription drug monitoring programs
    Ashburn, Michael A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 (07) : 852 - 853
  • [9] Privacy and Prescription Drug Monitoring Programs
    Vivian, Jesse C.
    US PHARMACIST, 2014, 39 (05) : 44 - 46
  • [10] Prescription Drug Monitoring Programs Reply
    Gugelmann, Hallam M.
    Perrone, Jeanmarie
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (09): : 912 - 913